Medical News

RSS

New Infrared Relief therapy now available for patients with diabetic neuropathies

Genesis Spine Associates now offers Infrared Relief - a new, highly effective pain management therapy using infrared light for patients suffering from diabetic neuropathies. This new therapy offers a simple, painless option for managing patients' pain without potentially dangerous drugs or surgery.

14 May 2010

HIV disease tends to progress at faster rate in infected individuals who consume more alcoholic drinks

HIV disease tends to progress at a faster rate in infected individuals who consume two or more alcoholic drinks a day, according to an important new paper in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 May 2010

Merit Medical Systems to acquire BioSphere Medical

Merit Medical Systems, Inc. today announced that it has signed a definitive merger agreement to acquire BioSphere Medical, Inc. in an all cash transaction valued at approximately $96 million, inclusive of all common equity and Series A Preferred preferences.

14 May 2010

Groups plead for more health funding as Chairman warns about cuts to proposed HHS budget

House Appropriations Committee Chairman David Obey, D-Wis., said Wednesday that groups pressing for $14 billion more in funding for education, health and labor programs will likely be disappointed because the budget proposed by President Barack Obama already faces cuts of about $3.5 billion in those areas.

14 May 2010

Federal officials say crackdown on Medicare fraud recovers $2.5 billion

The Associated Press: "The government says it recovered $2.5 billion in overpayments for the Medicare trust fund last year as the Obama administration focused attention on fraud enforcement efforts in the health care industry. Investigators have new tools this year to help crack down on health care fraud, with the Justice Department and the Health and Human Services Department working cooperatively to police companies.

14 May 2010

Cyclacel Pharmaceuticals reports net loss of $5.1M for first-quarter 2010

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the first quarter ended March 31, 2010.

14 May 2010

Derma Sciences first-quarter net sales up 23% to $12,844,382

Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, reported financial and operating results today for the three months ended March 31, 2010.

14 May 2010

Calcium deficiency may make people more prone to osteoporosis, obesity in later life: Study

There's no denying that people need calcium for strong, healthy bones. But new research from North Carolina State University suggests that not getting enough calcium in the earliest days of life could have a more profound, lifelong impact on bone health and perhaps even obesity than previously thought.

14 May 2010

Today's Opinions: CBO numbers undercut health law promises; Concerns about Berwick nomination; The recission myth

The Democrats' reform is barely out of the gate and the Congressional Budget Office already says its previous cost estimate was too low. Either the bill's supporters lied or they're profoundly ignorant. Either way, they are not fit to serve the country, much less rule it, which many of them seem to believe is their divine right. As noted on these pages and elsewhere, government programs always cost far more than their original projections (5/12).

14 May 2010

Chimerix commences first-in-human study of CMX157 for HIV

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.

14 May 2010

Boston Scientific's ACUITY Break-Away Lead Delivery System receives FDA clearance

Boston Scientific Corporation today announced U.S. Food and Drug Administration clearance of the ACUITY Break-Away Lead Delivery System for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, both of which treat heart failure.

14 May 2010

Home health care stocks fall with Senate Finance Committee inquiry

Shares of four home health care providers tumbled Thursday after the Senate Finance Committee raised questions about how the companies bill Medicare for home health therapy visits, The Associated Press/ABC News reports.

14 May 2010

Accellent's first-quarter 2010 revenue increased 10.8% to $122.7 million

Accellent Inc., a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal first quarter ended March 31, 2010.

14 May 2010

Canadian tourist bitten by a Katipo spider in New Zealand

A Canadian tourist suffered a serious heart inflammation called myocarditis after he was bitten by a poisonous spider when he went swimming nude in New Zealand.

13 May 2010

Being physical and mental activity delays onset of Huntington’s disease: Research

Melbourne researchers report in a study that regular physical and mental activities can delay the onset of the dreaded genetic Huntington's disease. This disease is hereditary and it goes on to destroy the brain and nerve cells leading to loss of all or most faculties. It affects one in 10,000 people between ages 30 and 50 and there is no cure. Since it is passed on to the children at least 50% of the time the decision to have children also becomes an agonizing one for many sufferers.

13 May 2010

Birner Dental Management Services first-quarter revenue increases 7.8% to $16.5 million

Birner Dental Management Services, Inc., operators of PERFECT TEETH® dental practices, announced results for the quarter ended March 31, 2010. For the quarter ended March 31, 2010, revenue increased $1.2 million, or 7.8%, to $16.5 million.

13 May 2010

Rexahn Pharmaceuticals announces Phase IIb clinical trial of Zoraxel for ED

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will initiate a Phase IIb clinical trial for ZoraxelTM in the treatment of erectile dysfunction (ED).

13 May 2010

ARCA biopharma regains compliance for continued listing on NASDAQ

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that it received notification from the NASDAQ Stock Market that the Company has demonstrated compliance with the minimum stockholders' equity requirement for the NASDAQ Global Market

13 May 2010

TechniScan awarded U.S. Patent for 3-D, Warm Bath Ultrasound system

A newly awarded U.S. Patent will protect TechniScan, Inc's., novel way to image, biopsy and treat breast cancer.

13 May 2010

Omnicare announces $400M senior subordinated notes offering

Omnicare, Inc. today announced that it intends to offer $400 million aggregate principal amount of senior subordinated notes due 2020, pursuant to a preliminary prospectus supplement to be filed with the Securities and Exchange Commission under the Company's shelf registration statement.

13 May 2010

Medical News

New Infrared Relief therapy now available for patients with diabetic neuropathies

HIV disease tends to progress at faster rate in infected individuals who consume more alcoholic drinks

Merit Medical Systems to acquire BioSphere Medical

Groups plead for more health funding as Chairman warns about cuts to proposed HHS budget

Federal officials say crackdown on Medicare fraud recovers $2.5 billion

Cyclacel Pharmaceuticals reports net loss of $5.1M for first-quarter 2010

Derma Sciences first-quarter net sales up 23% to $12,844,382

Calcium deficiency may make people more prone to osteoporosis, obesity in later life: Study

Today's Opinions: CBO numbers undercut health law promises; Concerns about Berwick nomination; The recission myth

Chimerix commences first-in-human study of CMX157 for HIV

Boston Scientific's ACUITY Break-Away Lead Delivery System receives FDA clearance

Home health care stocks fall with Senate Finance Committee inquiry

Accellent's first-quarter 2010 revenue increased 10.8% to $122.7 million

Canadian tourist bitten by a Katipo spider in New Zealand

Being physical and mental activity delays onset of Huntington’s disease: Research

Birner Dental Management Services first-quarter revenue increases 7.8% to $16.5 million

Rexahn Pharmaceuticals announces Phase IIb clinical trial of Zoraxel for ED

ARCA biopharma regains compliance for continued listing on NASDAQ

TechniScan awarded U.S. Patent for 3-D, Warm Bath Ultrasound system

Omnicare announces $400M senior subordinated notes offering

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News